The group of neurodegenerative diseases, Parkinson's disease (PD), dementia with Lewy bodies (DLB), and 11 multiple system atrophy (MSA) all exhibit inclusions containing amyloid-type α-synuclein (α-syn) aggregates 12 within degenerating brain cells. α-syn also exists as soluble oligomeric species that are hypothesized to 13 represent intermediates between its native and aggregated states. These oligomers are present in brain 14 extracts from patients suffering from synucleinopathies and hold great potential as biomarkers. Although 15 easily prepared in vitro, oligomers are metastable and dissociate over time, thereby complicating α-syn 16 oligomer research. Using the small amine-reactive cross-linker, formaldehyde (FA), we successfully stabilized 17 α-syn oligomers without affecting their size, overall structure or antigenicity towards aggregate-18 conformation specific α-syn antibodies FILA and MJFR-14-6-4-2. Further, cross-linked α-syn oligomers show 19 resistance towards denaturant like urea and SDS treatment and remain fully functional as internal standard 20 in an aggregation-specific enzyme-linked immunosorbent assay (ELISA) despite prior incubation with urea.
Introduction 25
Parkinson's disease (PD), Dementia with Lewy Bodies (DLB) and Multiple System Atrophy (MSA) are the three 26 main types of synucleinopathies, all of which are characterized by inclusions mainly consisting of intracellular 27 aggregated α-synuclein (α-syn); a 140-amino acid protein with hypothesized unfolded native appearance [1,
28 2]. α-syn is widely expressed in the brain and mainly localizes to the presynaptic terminals where it is believed 29 to play a role as a SNARE-complex chaperone, necessary for binding of vesicles and the release of 30 neurotransmitter in the synaptic cleft [3, 4] . Proof of the involvement of α-syn in PD is evident from familial 31 cases, where specific point mutations or multiple copies of the normal α-syn gene, SNCA, causes autosomal 32 PD [5] [6] [7] [8] . Under normal physiological conditions, α-syn exists as a native species in the brain, but aggregates 33 into larger insoluble fibrils under pathological conditions [9] . However, α-syn also exists in an intermediate 34 state, as an aggregated soluble species, called oligomers. Oligomers have been found in post-mortem brain 35 extracts from both DLB, PD and MSA patients [10] [11] [12] , and accumulating evidence indicates that oligomers 36 are responsible for the toxicity seen in the brain of patients suffering from synucleinopathies [13] [14] [15] .
37
Furthermore, in vitro generated oligomers are capable of seeding and mediate cell-to-cell spreading linked 38 to the prion-like spreading seen in PD [16] . α-syn oligomers can be generated in vitro in several ways, such 39 as chemical modification by dopamine, ethanol and Fe 3+ and high protein concentration [17] [18] [19] . Oligomers 40 formed spontaneously at high protein concentration have also shown similarities with patient-derived in vivo 41 oligomers in the antigenicity towards aggregation-specific antibodies [10] . However, these oligomers are 42 metastable and dissociate into monomers over time [20] . Therefore, an in vivo representative α-syn 43 oligomer-standard used to study the underlying mechanistic pathways and aid in the search for 44 synucleinopathy-specific biomarkers, is of great interest. Using formaldehyde (FA) crosslinking, we have 45 successfully stabilized α-syn in its oligomeric state without disturbing antigenicity and biochemical 46 properties, thereby providing a much-needed calibrating tool, which enables comparative and standardized research within the field of oligomeric α-syn.
48

Results
49
Characterizing native α-syn oligomers 50 Brief incubating of high concentration of α-syn at 0 o C has previously been shown to spontaneously generate 51 oligomeric species [19] [20] [21] . Using this method, in combination with size-exclusion chromatography, we 52 successfully separated oligomers from monomers and obtained a pure oligomeric fraction ( Fig 1A) . Dynamic 53 light scattering (DLS) confirmed the different sizes of the α-syn monomers and oligomers, showing two 54 distinct species, with an average radius of 3.6 ± 0.3 and 49.7 ± 2.6 nm respectively ( Fig. 1B ). Monomers and 55 oligomers both bind the α-syn specific antibodies BD and ASY1 that recognizes total α-syn levels, whereas 56 only the oligomers specifically binds the two aggregation-specific antibodies, FILA and MJF14 (Fig. 1C ).
57
Transmission electron microscopy (TEM) revealed a twisted ribbon-like structure of the purified α-syn 58 oligomers, which corresponds well with previous observation of oligomeric α-syn ( Fig. 1D ) [22] . The α-syn 59 oligomers clearly differ from the well-ordered structure and size of the preformed α-syn fibrils ( Fig. 1E ).
61
Stabilization of the α-syn oligomers using formaldehyde 62 α-syn oligomers consist of non-covalently bound monomers that easily dissociate into monomers upon 63 boiling in SDS prior to SDS-PAGE ( Fig. 2A, right) . However, incubation of the α-syn oligomers with increasing 64 concentration of the small amine-reactive cross-linker, formaldehyde (FA), prior to SDS-PAGE, stabilized the 65 α-syn multimers as evident from a depletion of the ~17kDa monomeric α-syn band ( Fig. 2A, right) . The 66 retention of immunoreactivity in the stacking gel demonstrates the cross-linking of α-syn into large stable 67 complexes (Fig 2A, right) . By contrast α-syn monomers incubated with identical FA concentrations did not 68 result in cross-linked-dependent depletion of the monomeric band nor accumulation of high molecular 69 weight species (Fig 2A, left) .
70
Visualization of FA-treated monomeric and oligomeric α-syn, using the aggregation-specific FILA antibody, 71 revealed that epitope-recognition was unaffected by cross-linking ( Fig. 2B ). The FA treated oligomers are also 72 less prone to disassembly, as FILA antigenicity after 3h incubation with denaturizing SDS, is still observed (Fig.   73 2B).
75
Optimization of cross-linking
76
To avoid excessive and unnecessary chemical modification of the oligomers, we carried out titration 77 experiments, aiming to find the lowest possible concentration of FA that efficiently stabilize α-syn oligomers.
78
Using 0.2-3.2% FA and incubation for 30-or 60 min, we found that 1.6% and 3.2% FA after 60 min resulted in 79 satisfactory cross-linking as measured by loss of the α-syn monomer-band (95 ± 4.6% and 98 ± 1.9% 80 respectively), when resolved on SDS-PAGE ( Fig. 3A-C) . Further, we assessed if antigenicity of α-syn monomers 81 or oligomers were affected by FA cross-linking. No difference was observed in oligomer recognition using 82 antibodies BD, ASY1, FILA and MJF14 at any concentration of FA ( Fig. 3D-G) , although a trend of high FA 83 concentrations masking the BD epitope of monomeric α-syn was observed ( Fig. 3E ). 3.2% FA incubation 84 generally results in a slightly higher cross-linking efficiency than 1.6% FA ( Fig. 3A and 3C ), but we chose to 85 continue with 1.6% FA for the remainder of the study for technical reasons. Primarily to avoid unnecessary 86 dilution of the oligomers by adding larger volumes of Tris to quench the FA cross-linker. To test the biophysical properties of the 1.6% FA cross-linked oligomers, we performed a DLS time-course 90 experiment, measuring the size-distribution of the oligomers after 0, 15, 30 and 60 min of 1.6% FA treatment.
91
Throughout the experiment, the size of the oligomers was unchanged, suggesting that the oligomers are 92 stabilized in their native structure and not cross-linked into larger complexes over time ( Fig. 4A ). EM 5 93 confirmed that the overall structure of the oligomers were kept after FA mediated cross-linking as these 94 resembled native oligomers ( Fig. 1D and 4B ).
95
In vitro formed α-syn oligomers are useful in many experimental setups. One example, is the application of 96 in vitro α-syn oligomers as internal standard in the newly developed aggregation-specific enzyme-linked 97 immunosorbent assay (ELISA) based on the aggregation-specific MJF14 antibody [23] ; an assay that 98 effectively assess levels of α-syn oligomers in cell and animal models. Using this method, we compared the 99 standard curves prepared from either native oligomers or FA cross-linked oligomers under different 100 conditions ( Fig. 4C ). We observed that ELISA standard curves using cross-linked oligomers were 101 indistinguishable from those prepared with native oligomers (Fig. 4C 
Figure legends
271
Figure 1. Generation and confirmation of in vitro generated α-syn oligomers and fibrils A) Oligomers
272 generated by resuspending lyophilised recombinant α-syn at high concentration (10mg/mL) incubated on ice 273 and subsequently isolated using gel-filtration. Oligomers (O) 2. Crosslinking of α-syn monomers and oligomers. A) 
